| Reference | FOI 2026/1776 |
|---|---|
| Description | Clinical Partners Right to Choose ADHD and Autism Services |
| Date Requested | 20/05/2026 |
| Date Replied | 17/06/2026 |
| Category | LDA Transformation |
Under the Freedom of Information Act 2000, please provide the following information relating to NHS-funded Right to Choose ADHD and autism assessments for children and young people provided by Clinical Partners for patients registered with NHS Greater Manchester Integrated Care Board.
Please provide information for the period 1 March 2025 to the date of this request.
If any of the requested information is exempt from disclosure, please provide the remaining information and explain the basis for any exemption relied upon.
NHS GM publishes a report on a monthly basis detailing the spend with suppliers over £25k within that given month. As such, details of the amount of funding paid to Clinical Partners Limited is already available to the applicant. These reports are published on the ICB’s website at NHS Greater Manchester Reports | Greater Manchester Integrated Care Partnership in the spending reports section. These are uploaded on a monthly basis, shortly following the end of the previous month.
Section 43(2) of the Freedom of Information Act 2000 states:
“Information is exempt information if its disclosure under this Act would, or would be likely to, prejudice the commercial interests of any person (including the public authority holding it)”.
Disclosure of this information would be likely to prejudice the commercial interests of both the provider and NHS GM by revealing commercially sensitive pricing and funding arrangements within a competitive healthcare market.
Factors favouring disclosure.
There is an inherent public interest in ensuring that there is openness and transparency in the spending of public money. Transparency is likely to increase confidence in procurement processes and the purchasing decisions made by NHS GM. It also enables the public to understand whether NHS GM is getting value for money from its purchasing decisions.
Factors favouring non-disclosure.
However, we believe that disclosure of the contract could prejudice the current or future negotiating capabilities of NHS GM. This information includes, but is not limited to, detailed pricing mechanisms, activity assumptions, service delivery models, and operational schedules. Disclosure of this information would be likely to prejudice the commercial interests of the providers and the negotiating capabilities of NHS GM, particularly in relation to future commissioning, negotiation and value-for-money considerations.
Disclosure of this information would be likely to prejudice the commercial interests of both the provider and NHS Greater Manchester ICB by revealing commercially sensitive operational activity levels and contractual arrangements within a competitive healthcare market.
Balancing Test.
After considering the arguments outlined above, we have decided to withhold this information.
NHS GM considers that the public interest in maintaining the exemption outweighs the public interest in disclosure, as releasing the information could weaken the ICB’s ability to secure best value in future commissioning and procurement activity.
Therefore, this information is exempt from disclosure under Section 43(2) of the Freedom of Information Act 2000, please refer to the response to questions 3 relating to commercial interests.
Therefore, this information is exempt from disclosure under Section 43(2) of the Freedom of Information Act 2000, please refer to the response to questions 3 relating to commercial interests.